Product Code: ETC417477 | Publication Date: Jul 2023 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States Corticosteroids market is expected to witness significant growth over the forecast period of 2020-2025. The rising prevalence of various chronic and autoimmune diseases such as asthma, arthritis, lupus erythematosus, inflammatory bowel disease (IBD), and multiple sclerosis are key drivers for the growth of the corticosteroid market in the US. Furthermore, increasing awareness among patients regarding novel delivery forms or modes including inhalers and injectables is anticipated to boost usage rates and further drive revenue generation. Additionally, drug manufacturers have intensified their investment in research & development activities for new product launches across different regions which renders a favorable outlook for this sector over the coming years.
Increasing incidence rate of chronic diseases such as bronchial asthma requiring systemic corticosteroid therapy will contribute significantly towards industry expansion. Higher spending capacity on healthcare treatments has propelled the demand for advanced treatment regimens like corticosteroids delivering improved efficacy outcomes that result in higher patient compliance. Increased availability of effective combination therapies containing steroids along with antibiotics providing enhanced therapeutic benefits compared to monotherapy will fuel sales volume 4. Growing focus on introducing innovative products with combined glucocorticoid/immunomodulator compounds offering additional clinical advantages leading to increased adoption rate by physicians
High risk associated with adverse side effects from long-term use may hamper usage rates thus limiting overall sales revenues generated from this sector. Stringent regulatory framework pertaining to the approval process adding extra cost burden while manufacturing steroid-based drugs can act as a deterrent against industry players.
Pfizer Inc., Merck & Co., Inc., Novartis AG, Sanofi S A, AstraZeneca Plc, AbbVie Inc., GlaxoSmithKline plc, Bristol Myers Squibb Company, etc .are some major innovators contributing significantly towards US Corticosteroids Market Landscape.
The outbreak has negatively impacted medical device industries due to disruption in supply chains coupled with a declining global economy resulting in reduced demand due to high costs involved during treatment procedures. However, introducing newer products facilitating efficient usage would play a pivotal role post-pandemic situation thus driving up demand levels and eventually aiding industry development.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Corticosteroids Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Corticosteroids Market Revenues & Volume, 2021 & 2028F |
3.3 United States (US) Corticosteroids Market - Industry Life Cycle |
3.4 United States (US) Corticosteroids Market - Porter's Five Forces |
3.5 United States (US) Corticosteroids Market Revenues & Volume Share, By Application, 2021 & 2028F |
3.6 United States (US) Corticosteroids Market Revenues & Volume Share, By End User, 2021 & 2028F |
4 United States (US) Corticosteroids Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United States (US) Corticosteroids Market Trends |
6 United States (US) Corticosteroids Market, By Types |
6.1 United States (US) Corticosteroids Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Corticosteroids Market Revenues & Volume, By Application, 2018 - 2028F |
6.1.3 United States (US) Corticosteroids Market Revenues & Volume, By Skin Allergies, 2018 - 2028F |
6.1.4 United States (US) Corticosteroids Market Revenues & Volume, By Rhuematology Indications, 2018 - 2028F |
6.1.5 United States (US) Corticosteroids Market Revenues & Volume, By Endocrinology, 2018 - 2028F |
6.1.6 United States (US) Corticosteroids Market Revenues & Volume, By Acute Respiratory Diseases, 2018 - 2028F |
6.1.7 United States (US) Corticosteroids Market Revenues & Volume, By Others, 2018 - 2028F |
6.2 United States (US) Corticosteroids Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Corticosteroids Market Revenues & Volume, By Hospitals, 2018 - 2028F |
6.2.3 United States (US) Corticosteroids Market Revenues & Volume, By Clinics, 2018 - 2028F |
6.2.4 United States (US) Corticosteroids Market Revenues & Volume, By Research Institutes, 2018 - 2028F |
6.2.5 United States (US) Corticosteroids Market Revenues & Volume, By Others, 2018 - 2028F |
7 United States (US) Corticosteroids Market Import-Export Trade Statistics |
7.1 United States (US) Corticosteroids Market Export to Major Countries |
7.2 United States (US) Corticosteroids Market Imports from Major Countries |
8 United States (US) Corticosteroids Market Key Performance Indicators |
9 United States (US) Corticosteroids Market - Opportunity Assessment |
9.1 United States (US) Corticosteroids Market Opportunity Assessment, By Application, 2021 & 2028F |
9.2 United States (US) Corticosteroids Market Opportunity Assessment, By End User, 2021 & 2028F |
10 United States (US) Corticosteroids Market - Competitive Landscape |
10.1 United States (US) Corticosteroids Market Revenue Share, By Companies, 2021 |
10.2 United States (US) Corticosteroids Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |